Biology subjects

Edwards, A. K.

Publications and source records attributed to Edwards, A. K..

4 recordsLinked to original sources

bioRxiv2025

Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy

Vascular Endothelial Growth Factor C (VEGF-C) is a key lymphangiogenic growth factor expressed by many types of cancer. Here, we investigated the effects of tumor-derived VEGF-C on the therapeutic efficacy of oncolytic virotherapy with avian paramyxoviruses APMV-1 (NDV) and AMPV-4. Treatment of B16F10 tumors not expressing VEGF-C with either virus led to tumor growth delay, and complete responses were rare. In contrast, when tumors expressed VEGF-C, viral therapy led to complete remission and long-term immunological memory in most mice. Upon re-challenge, most mice remained tumor- and metastasis-free for over 18 months, indicating durable immunity. VEGF-C induced tumor lymphangiogenesis, which correlated with high CD8+ and CD4+ T-cell densities in proximity of lymphatic vessels. Spectral flow cytometry revealed distinct changes in the composition and activation of CD8+, CD4+ T cells and NK cells associated with complete remission. In responders, tumors were highly enriched in CD8+CD25+ PD-1+ effector T cells. Composition of T cells was altered in sentinel and in contralateral lymph nodes, indicating a systemic immune response. Taken together, these data demonstrate VEGF-C-induced changes in tumor immune landscape which are critical for achieving complete response and support combining VEGF-C with APMV virotherapy as a novel highly effective strategy for cancer treatment.

cancer biology↗

bioRxiv2024

A shade-responsive microProtein in the Arabidopsis ATHB2 gene regulates elongation growth and root development

Shade triggers widespread changes in transcript isoform production in Arabidopsis thaliana. Using 5' PEAT sequencing, we identified 377 candidate microprotein-encoding transcripts arising from alternative transcription start sites, including one located within the third exon of ATHB2, a class II HD-ZIP transcription factor central to shade avoidance. The encoded microprotein, ATHB2miP, lacks the DNA-binding homeodomain but retains the leucine zipper domain, through which it forms heterodimers with full-length ATHB2, inhibits its DNA-binding activity, and disrupts its localization to nuclear photobodies. Ectopic expression of ATHB2miP phenocopies loss of ATHB2, deregulating genes involved in auxin signaling, root development, and iron homeostasis. Complementation of the athb2 mutant with a construct carrying a silent mutation at the ATHB2miP start codon results in exaggerated hypocotyl elongation under both white light and shade, demonstrating that ATHB2miP is required to restrain excessive elongation growth. Immunoprecipitation mass spectrometry confirmed that this mutation redirects translation to alternative initiation sites, producing distinct proteoforms absent from wild-type plants. Additionally, ATHB2 suppresses iron uptake genes, and iron availability modulates shade growth responses in an ATHB2-dependent manner. Together, these findings establish ATHB2miP as a regulator of an ATHB2 feedback circuit that integrates light and nutritional signals to coordinate shoot elongation and root development.

plant biology↗

bioRxiv2022

The m6A writer FIONA1 methylates the 3'UTR of FLC and controls flowering in Arabidopsis

Adenosine bases of RNA can be transiently modified by the deposition of a methyl-group to form N6-methyladenosine (m6A). This adenosine-methylation is an ancient process and the enzymes involved are evolutionary highly conserved. A genetic screen designed to identified suppressors of late flowering transgenic Arabidopsis plants overexpressing the miP1a microProtein yielded a new allele of the FIONA1 (FIO1) m6A-methyltransferase. To characterize the early flowering phenotype of fio1 mutant plants we employed an integrative approach of mRNA-seq, Nanopore direct RNA-sequencing and meRIP-seq to identify differentially expressed transcripts as well as differentially methylated mRNAs. We provide evidence that FIO1 is the elusive methylase responsible for the 3-end methylation of the FLOWERING LOCUS C (FLC) transcript. Furthermore, our genetic and biochemical data suggest that 3-methylation stabilizes FLC mRNAs and non-methylated FLC is a target for rapid degradation.

plant biology↗

bioRxiv2017

Pathway-based polygenic risk implicates GO: 17144 drug metabolism in recurrent depressive disorder

The Psychiatric Genomics Consortium (PGC) has made major advances in the molecular etiology of MDD, confirming that MDD is highly polygenic, with any top risk loci conferring a very small proportion of variance in case-control status (1). Pathway enrichment results from PGC meta-analyses can also be used to help inform molecular drug targets. Prior to any knowledge of molecular biomarkers for MDD, drugs targeting molecular pathways have proved successful in treating MDD. However, it is possible that with information from PGC analyses, examining specific molecular pathway(s) implicated in MDD can further inform our study of molecular drug targets. Using a large case-control GWAS based on low-coverage whole genome sequencing (N = 10,640), we derived polygenic risk scores for MDD and for MDD specific to each of over 300 molecular pathways. We then used these data to identify sets of scores significantly predictive of case status, accounting for critical covariates. Over and above global polygenic risk for MDD, polygenic risk within the GO: 17144 drug metabolism pathway significantly predicted recurrent depression. In transcriptomic analyses, two pathway genes yielded suggestive signals at FDR q-values = .054: CYP2C19 (family of Cytochrome P450) and CBR1 (Carbonyl Reductase 1). Because the neuroleptic carbamazepine is a known inducer of CYP2C19, future research might examine whether drug metabolism PRS has any influence on clinical presentation and treatment response. Overall, results indicate that pathway-based risk might inform treatment of severe depression. We discuss limitations to the generalizability of these preliminary findings, and urge replication in future research.

genetics↗